(Total Views: 53)
Posted On: 12/09/2024 1:44:13 PM
Post# of 35596
$DYAI Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology https://finance.yahoo.com/news/dyadic-receive...00271.html
(0)
(0)
Scroll down for more posts ▼